These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11779776)

  • 1. Lupus relapse after prostaglandin E(1) administration: activation of a cytokine cascade?
    de la Torre M; Alcázar R; Sánchez de la Nieta D; Nieto J; Ferreras I; Urra JM
    Ann Rheum Dis; 2002 Jan; 61(1):91-2. PubMed ID: 11779776
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of vasospastic disease with prostaglandin E1.
    Cleophas AJ; Fennis JF; van't Laar A
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1476. PubMed ID: 6784876
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin E-1 and peripheral vascular disease.
    Kyle V; Hazleman B
    Lancet; 1983 Jul; 2(8344):282. PubMed ID: 6135105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripheral gangrene in lupus erythematosus].
    Metz G; Schubert E; Metz J
    Munch Med Wochenschr; 1971 May; 113(19):729-34. PubMed ID: 5108320
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandin therapy in severe limb ischemia.
    Pardy BJ; Eastcott HH
    World J Surg; 1983 May; 7(3):353-62. PubMed ID: 6349140
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application to the surgical field].
    Mishima Y
    Nihon Rinsho; 1985 Mar; 43(3):598-602. PubMed ID: 3892091
    [No Abstract]   [Full Text] [Related]  

  • 7. Botulinum toxin-A for the treatment of Raynaud syndrome.
    Smith L; Polsky D; Franks AG
    Arch Dermatol; 2012 Apr; 148(4):426-8. PubMed ID: 22508867
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug therapy of vasculitis with prostaglandins].
    Makino S
    Nihon Rinsho; 1985 Oct; 43(10):2200-5. PubMed ID: 3912548
    [No Abstract]   [Full Text] [Related]  

  • 9. Do cytokines play a role in systemic lupus erythematosus?
    Singh AK
    J R Coll Physicians Lond; 1992 Oct; 26(4):374-6. PubMed ID: 1432876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 vasospastic disease and thermography.
    Kyle V; Parr G; Salisbury R; Thomas PP; Hazleman B
    Ann Rheum Dis; 1985 Feb; 44(2):73-8. PubMed ID: 3977414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.
    Lucas GS; Simms MH; Caldwell NM; Alexander SJ; Stuart J
    J Clin Pathol; 1984 Aug; 37(8):870-3. PubMed ID: 6540787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus].
    Mikulska D
    Ann Acad Med Stetin; 2009; 55(3):23-7. PubMed ID: 20698174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raynaud's phenomenon and systemic lupus erythematosus (author's transl)].
    Zitnan D; Tauchmannová H; Lukác J; Cebecauer L; Rovenský J
    Bratisl Lek Listy; 1981 May; 75(5):529-37. PubMed ID: 7237182
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of vasospastic disease with prostaglandin E1.
    Clifford PC; Martin MF; Sheddon EJ; Kirby JD; Baird RN; Dieppe PA
    Br Med J; 1980 Oct; 281(6247):1031-4. PubMed ID: 7427564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin I2 and E1 and red cell deformability in raynaud's phenomenon and systemic sclerosis.
    Gaylarde PM
    Br Med J (Clin Res Ed); 1981 Dec; 283(6306):1608-9. PubMed ID: 6796187
    [No Abstract]   [Full Text] [Related]  

  • 16. [Postoperative management of a case of SLE and mitral stenosis combined with severe pulmonary hypertension: effect of prostaglandin E1].
    Atsumi N; Mizuhara A; Sakai A; Tsutsui T; Okamura K; Maeta H; Ijima H; Mitsui T; Hori M; Doi M
    Kokyu To Junkan; 1987 Oct; 35(10):1099-103. PubMed ID: 3423442
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of inflammatory reactions by prostaglandins.
    Kunkel SL; Fantone JC; Ward PA; Zurier RB
    Prog Lipid Res; 1981; 20():633-40. PubMed ID: 6210914
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lupus erythematosus with muscular involvement and Raynaud's syndrome].
    Gajkowski K
    Neurol Neurochir Pol; 1974; 8(1):109-12. PubMed ID: 4135376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multiple vascular disorders in a patient with visceral lupus erythematosus].
    Bureau Y; Barrière H; Litoux P; Bureau B
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(4):581-3. PubMed ID: 5368298
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandin E1 in severe Raynaud's phenomenon.
    Pardy BJ; Hoare MC; Eastcott HH; Miles CC; Needham TN; Harbourne T; Ellis BW
    Surgery; 1982 Dec; 92(6):953-65. PubMed ID: 6890719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.